CDC’s Investments to Combat Antibiotic Resistance Threats: Minnesota: Fiscal Year 2021

Details

• Corporate Authors:
  Centers for Disease Control and Prevention (U.S.)
• Description:
  $5,310,927 Funding for AR Activities Fiscal year 2021 ; Two local CDC fellows & One local CDC AR expert ; Regional Lab for the AR Lab Network (Central) ; One of 10 sites for the Emerging Infections Program ; See CDC’s AR investments by state at www.cdc.gov/ARinvestments. ; Publication date from document properties. ; Minnesota-CDC-AR-Investments.pdf
• Subjects:
  • Antimicrobial Stewardship
  • Carbapenem-Resistant Enterobacteriaceae
  • Communicable Diseases, Emerging
  • Cross Infection/prevention & control
  • Drug Resistance, Microbial
  • Financing, Government
  • Food Safety
  • Gonorrhea/prevention & control
  • Local Government
  • Public Health
  More +
• Series:
  Antibiotic Resistance (AR) Solutions in Action
• Document Type:
  Text
• Genre:
  Fact Sheet
• Place as Subject:
  Minnesota
• Pages in Document:
  2 numbered pages
• Federal Fiscal Year:
  2021
• Download URL:
  https://stacks.cdc.gov/view/cdc/115403/cdc_115403_DS1.pdf
• File Type:
  [PDF - 517.55 KB]
• Collection(s):
  Stephen B. Thacker CDC Library
• Main Document Checksum:
  urn:sha-512:f13a9dc12df6492b6c60b48ca1b9a8889a5a6ee952b7b207219a1c2aeb2375ef710a612cdcdd794f64f79ca26f4a3ba8ba36021bb791e4f0082486029974d7d4